HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 288 filers reported holding HORIZON PHARMA PLC in Q1 2019. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $33,382,000 | +60.7% | 1,263,053 | +18.8% | 2.44% | +24.9% |
| Q4 2018 | $20,774,000 | +6.7% | 1,063,165 | +6.9% | 1.95% | +28.6% |
| Q3 2018 | $19,470,000 | -10.6% | 994,358 | -24.4% | 1.52% | +0.9% |
| Q2 2018 | $21,779,000 | +62.6% | 1,315,149 | +43.3% | 1.50% | +59.1% |
| Q4 2017 | $13,395,000 | +205.9% | 917,471 | +165.6% | 0.95% | +89.6% |
| Q3 2017 | $4,379,000 | -27.0% | 345,386 | -31.7% | 0.50% | -17.5% |
| Q2 2017 | $6,001,000 | -16.1% | 505,590 | +4.5% | 0.60% | -14.4% |
| Q1 2017 | $7,150,000 | -3.8% | 483,763 | +5.3% | 0.71% | +5.4% |
| Q4 2016 | $7,433,000 | -15.4% | 459,386 | -5.2% | 0.67% | -0.1% |
| Q3 2016 | $8,781,000 | +109.9% | 484,356 | +90.7% | 0.67% | +75.0% |
| Q2 2016 | $4,184,000 | +28.1% | 254,046 | +28.9% | 0.38% | +18.2% |
| Q1 2016 | $3,265,000 | +34.9% | 197,047 | +76.4% | 0.32% | +25.5% |
| Q4 2015 | $2,420,000 | +57.2% | 111,682 | +43.8% | 0.26% | +26.3% |
| Q3 2015 | $1,539,000 | – | 77,674 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
| KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
| CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
| EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
| USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
| Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
| C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
| Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
| Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
| FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |